Short revision bullets only, not a replacement for the full lesson sections below.
Toggle for a short revision list before a mock or question block.
Pathophysiology
Clinical meaning
Ascites is the pathological accumulation of fluid within the peritoneal cavity, most commonly caused by portal hypertension in the setting of cirrhosis (accounting for approximately 85% of cases). Understanding the cellular and hemodynamic mechanisms underlying ascites formation is essential for effective nursing assessment and management.
In cirrhosis, chronic hepatocyte injury from alcohol, viral hepatitis, or non-alcoholic steatohepatitis triggers hepatic stellate cell activation and progressive fibrosis. Fibrotic bands and regenerative nodules distort the hepatic architecture, increasing resistance to portal blood flow. Portal pressure rises from the normal gradient of 1 to 5 mmHg to above 10 to 12 mmHg (the threshold for ascites formation), a state called clinically significant portal hypertension. The increased portal pressure raises hydrostatic pressure in the splanchnic capillary bed, favoring fluid transudation into the peritoneal cavity.
Simultaneously, portal hypertension induces splanchnic vasodilation through increased production of nitric oxide (NO), carbon monoxide, and endogenous cannabinoids by the splanchnic endothelium. This vasodilation reduces effective arterial blood volume (EABV), activating neurohormonal compensatory systems: the renin-angiotensin-aldosterone system (RAAS), the sympathetic nervous system (SNS), and non-osmotic release of antidiuretic hormone (ADH/vasopressin). These systems promote renal sodium and water retention, expanding plasma volume. However, the retained fluid preferentially distributes to the splanchnic circulation (the path of least resistance due to vasodilation and portal hypertension), perpetuating ascites formation in a self-reinforcing cycle known as the peripheral arterial vasodilation hypothesis.
Hypoalbuminemia from impaired hepatic synthetic function reduces plasma oncotic pressure (albumin provides approximately 80% of intravascular oncotic pressure), further favoring fluid movement from the intravascular space into the peritoneal cavity. Normal serum albumin is 3.5 to 5.0 g/dL; in advanced cirrhosis, levels often fall below 2.5 g/dL. The serum-ascites albumin gradient (SAAG) calculated as serum albumin minus ascites albumin, is the most reliable test to determine the cause of ascites. A SAAG greater than or equal to 1.1 g/dL indicates portal hypertension as the cause (cirrhosis, heart failure, Budd-Chiari syndrome) with 97% accuracy. A SAAG less than 1.1 g/dL indicates non-portal-hypertensive causes (peritoneal carcinomatosis, tuberculosis, nephrotic syndrome, pancreatitis).
Ascitic fluid analysis is critical for identifying spontaneous bacterial peritonitis (SBP), a life-threatening infection of ascitic fluid occurring in 10 to 30% of hospitalized cirrhotic patients with ascites. SBP results from bacterial translocation across the edematous, permeable intestinal wall of portal-hypertensive patients (most commonly enteric gram-negative organisms such as Escherichia coli, Klebsiella pneumoniae, and streptococcal species). Diagnosis requires an ascitic fluid polymorphonuclear neutrophil (PMN) count of 250 cells/mm3 or greater, with or without positive culture. SBP carries a 20 to 40% in-hospital mortality rate and signals advanced liver disease with poor prognosis.
Ascites management follows a stepwise approach. Grade 1 (mild) ascites detectable only by ultrasound is managed with sodium restriction (less than 2 grams per day). Grade 2 (moderate) ascites with visible abdominal distension is treated with sodium restriction plus diuretics (spironolactone as first-line, often combined with furosemide in a 100:40 mg ratio). Grade 3 (large or tense) ascites requires large-volume paracentesis (LVP) with albumin infusion (6 to 8 grams per liter removed when more than 5 liters drained) to prevent post-paracentesis circulatory dysfunction (PPCD). Refractory ascites (unresponsive to maximum diuretic doses or recurring rapidly after LVP) may require transjugular intrahepatic portosystemic shunt (TIPS) placement or liver transplant evaluation.
Exam Focus
Exam relevance
Risk factors:
- Cirrhosis from any cause (alcohol, hepatitis B/C, NASH - accounts for 85% of ascites cases)
- Clinically significant portal hypertension (portal pressure gradient greater than 10 to 12 mmHg)
- Hypoalbuminemia (serum albumin less than 2.5 g/dL from impaired hepatic synthesis)
- Continued alcohol use in patients with alcoholic liver disease (prevents hepatic recovery)
- Hepatocellular carcinoma (may worsen portal hypertension or cause peritoneal carcinomatosis)
- Heart failure (right-sided or biventricular, causing hepatic congestion and portal hypertension)
- High dietary sodium intake (exceeding renal sodium excretion capacity in cirrhotic patients)
Diagnostics:
- Diagnostic paracentesis: required for all new-onset ascites and all hospital admissions with ascites; obtain cell count with differential (PMN count 250 or greater indicates SBP), total protein, albumin, culture (inoculate blood culture bottles at bedside), glucose, and LDH
- Serum-ascites albumin gradient (SAAG): serum albumin minus ascites albumin; SAAG 1.1 or greater indicates portal hypertension; SAAG less than 1.1 indicates non-portal-hypertensive cause
- Abdominal ultrasound with Doppler: confirms ascites, assesses liver size and echogenicity, evaluates portal vein patency and flow direction, screens for hepatocellular carcinoma
- Serum labs: complete metabolic panel (sodium, creatinine, BUN for hepatorenal syndrome screening), albumin, INR/PT (synthetic function), CBC (thrombocytopenia from splenic sequestration in portal hypertension)
- 24-hour urine sodium collection or spot urine sodium: assess response to diuretic therapy; goal urinary sodium excretion greater than dietary sodium intake; spot urine sodium greater than urinary potassium suggests adequate diuretic response
- MELD score calculation (bilirubin, INR, creatinine, sodium) to assess liver disease severity, prognosis, and transplant priority
Core concept
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
Clinical scenario
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
Takeaways
Additional clinical detail, exam hooks, and takeaways continue in the full lesson.
Unlock full lesson + practice questions
3 more sections with scenarios, priorities, and review drills.
We didn’t match sample stems to this lesson in the bank yet. You can still run a topic-scoped drill with the same pathway filters—items load from your live NCLEX-RN pool.
